NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 31 filers reported holding NEUROBO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $91,000 | -12.5% | 20,642 | +4.3% | 0.05% | -8.8% |
| Q4 2020 | $104,000 | -18.1% | 19,792 | -12.7% | 0.06% | -16.2% |
| Q3 2020 | $127,000 | -99.9% | 22,682 | 0.0% | 0.07% | -34.0% |
| Q2 2020 | $182,591,000 | -42.1% | 22,682 | 0.0% | 0.10% | -44.3% |
| Q1 2020 | $315,280,000 | -51.1% | 22,682 | -33.6% | 0.18% | -43.3% |
| Q4 2019 | $644,560,000 | – | 34,176 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $214,000 | 0.02% |
| UBS Group AG | 1,037 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 371 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 323 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 24,642 | $92,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 728 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 60,792 | $226,000 | 0.00% |
| STATE STREET CORP | 15,878 | $59,000 | 0.00% |
| MORGAN STANLEY | 141 | $0 | 0.00% |